Skip to content

Vericel VCEL Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

LeMaitre Vascular logo
LeMaitre VascularLMAT
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
Globus Medical logo
Globus MedicalGMED
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's accrued liabilities, current?
Vericel (VCEL) reported accrued liabilities, current of $13.97M in Q1 2026.
How has Vericel's accrued liabilities, current changed year-over-year?
Vericel's accrued liabilities, current increased by 22.3% year-over-year, from $11.42M to $13.97M.
What is the long-term trend for Vericel's accrued liabilities, current?
Over 5 years (2020 to 2025), Vericel's accrued liabilities, current has grown at a 11.2% compound annual growth rate (CAGR), from $11.29M to $19.24M.